When we profiled LLNKF in a special report yesterday morning, we mentioned that the stock was ‘dripping with upside potential‘, and we were essentially proven right immediately. The stock traded more volume than the two prior sessions combined (23X the 30-day average) as it ran from a low of .1157 on up to .197, which represented an intraday rise of 70%
LLNKF closed just a couple of ticks below its high of day, at .195, and anytime we see a stock do so, especially with increased volume and buying pressure, we definitely want to be on the lookout for a possible continuation of momentum. We’ll look for this play to register higher highs and higher lows and continue this bullish uptrend.
Zynerba Pharmaceuticals, Inc. ZYNE – Recap
We are going to revisit ZYNE this morning, a stock that we have been tracking since back in December, with a followup at the end of January, as well as another just a couple of weeks ago on April 30th. Throughout that period of time, ZYNE has appreciated by leaps and bounds.
Starting from the low we observed shortly following our December alert, at 2.75, the stock has run all the way up to an impressive new high of 15.98 this week. That marks an overall move of 481% since we’ve been watching this play. Readers who may have only caught the most recent report on April 30th, have still seen a range of 9.57-15.98- a very respectable upswing of 67%
Fresh Options Ideas:
PINS Weekly $27-25.50 Puts*
DE Weekly $140-138 Puts*
*As always, we urge readers not to trade weekly options on a Friday if they are not advanced-level traders with access to disposable funds.
ADOM, GSAT, GEVO, OCUL, ACRX